PET developer CTI may soon go public. The privately held firm based in Knoxville, TN, has filed with the Securities and Exchange Commission to issue an IPO. The company hopes to raise about $230 million, according to Wall Street Research Net. The lead
PET developer CTI may soon go public. The privately held firm based in Knoxville, TN, has filed with the Securities and Exchange Commission to issue an IPO. The company hopes to raise about $230 million, according to Wall Street Research Net. The lead underwriter will be CS First Boston. CTI had annual revenues of $188.9 million and net income of $6.4 million in fiscal 2001, which ended Sept. 30. The company employs 620 full- and part-time staff, according to WSRN.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.